M LC 300 (Lithium carbonate extended release 300 mg)

Pill imprint M LC 300 has been identified as Lithium carbonate extended release 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; depression; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M LC 300 (Lithium carbonate extended release 300 mg)

Lithium carbonate extended release 300 mg M LC 300
Lithium carbonate extended release
LC 300
300 mg
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)